SARS-CoV-2-IN-64

SARS-CoV-2-IN-64

• UNSPSC Description: SARS-CoV-2-IN-64 (compound 9), a chenodeoxycholic acid derivative, is a potent inhibitor of spike glycoprotein of SARS-CoV-2[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-64.html
• Solubility: 10 mM in DMSO
• Smiles: ClC1=CC=C(C=C1)C(O[C@H]2C[C@]([H])([C@@]3(CC2)C)C[C@H]([C@@]4([C@@]3(CC[C@]5([C@]4(CC[C@@H]5[C@H](C)CCC(OC(C)C)=O)[H])C)[H])[H])OC(C6=CC=C(C=C6)Cl)=O)=O
• Molecular Weight: 711.75
• References & Citations: [1]Gisele Rocha Aguiar, et al. Synthesis and in silico study of chenodeoxycholic acid and its analogues as an alternative inhibitor of spike glycoprotein of SARS-CoV-2. J Biomol Struct Dyn. 2023 Oct-Nov;41(17):8334-8348.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported